Herman Miller Com Stk (MLHR) Shareholder Zebra Capital Management Decreased Stake as Stock Rose; As Abbvie (ABBV) Market Value Rose, Shareholder King Wealth Management Group Has Decreased Position

February 21, 2018 - By Peter Erickson

Roger Ibbotson decreased its stake in Herman Miller Inc Com Stk (MLHR) by 13.79% based on its latest 2017Q3 regulatory filing with the SEC. Zebra Capital Management Llc sold 10,686 shares as the company’s stock rose 5.47% with the market. The hedge fund run by Roger Ibbotson held 66,817 shares of the consumer durables company at the end of 2017Q3, valued at $2.40M, down from 77,503 at the end of the previous reported quarter. Zebra Capital Management Llc who had been investing in Herman Miller Inc Com Stk for a number of months, seems to be less bullish one the $2.25 billion market cap company. The stock increased 2.73% or $1 during the last trading session, reaching $37.65. About 84,578 shares traded. Herman Miller, Inc. (NASDAQ:MLHR) has risen 6.46% since February 21, 2017 and is uptrending. It has underperformed by 10.24% the S&P500.

King Wealth Management Group Llc decreased its stake in Abbvie Inc (ABBV) by 30.49% based on its latest 2017Q3 regulatory filing with the SEC. King Wealth Management Group Llc sold 14,269 shares as the company’s stock rose 6.17% with the market. The institutional investor held 32,536 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $2.89M, down from 46,805 at the end of the previous reported quarter. King Wealth Management Group Llc who had been investing in Abbvie Inc for a number of months, seems to be less bullish one the $190.60B market cap company. The stock increased 1.74% or $2.05 during the last trading session, reaching $120.03. About 2.38M shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since February 21, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on April, 26. They expect $1.78 EPS, up 39.06% or $0.50 from last year’s $1.28 per share. ABBV’s profit will be $2.83 billion for 16.86 P/E if the $1.78 EPS becomes a reality. After $1.48 actual EPS reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 20.27% EPS growth.

Since September 11, 2017, it had 0 buys, and 5 insider sales for $25.59 million activity. Michael Robert A. also sold $589,512 worth of AbbVie Inc. (NYSE:ABBV) shares. $8.57M worth of AbbVie Inc. (NYSE:ABBV) was sold by RICHMOND TIMOTHY J. on Monday, December 18. SALEKI-GERHARDT AZITA sold $705,655 worth of stock or 8,300 shares. The insider Schumacher Laura J sold $14.07 million.

King Wealth Management Group Llc, which manages about $1.58B and $269.01M US Long portfolio, upped its stake in Amazon Com Inc (NASDAQ:AMZN) by 411 shares to 2,130 shares, valued at $2.05M in 2017Q3, according to the filing.

Investors sentiment decreased to 0.85 in 2017 Q3. Its down 0.15, from 1 in 2017Q2. It turned negative, as 55 investors sold ABBV shares while 640 reduced holdings. 132 funds opened positions while 462 raised stakes. 1.06 billion shares or 1.89% more from 1.04 billion shares in 2017Q2 were reported. Bedell Frazier Investment Counseling Ltd Limited Liability Company holds 82,908 shares or 3.4% of its portfolio. The Wisconsin-based Cap Invest Service Of America has invested 0.05% in AbbVie Inc. (NYSE:ABBV). 152,684 were accumulated by Markston International Ltd Llc. Moreover, Atwood Palmer has 0.06% invested in AbbVie Inc. (NYSE:ABBV) for 4,750 shares. Personal Advisors Corporation holds 0.01% in AbbVie Inc. (NYSE:ABBV) or 4,907 shares. Rand Wealth Ltd Liability Corporation holds 0.46% or 45,314 shares in its portfolio. Girard owns 13,148 shares. Healthcor Mngmt L P, New York-based fund reported 986,320 shares. Hennessy has invested 0.32% in AbbVie Inc. (NYSE:ABBV). Fred Alger Management accumulated 141,637 shares or 0.06% of the stock. Washington Trust Savings Bank reported 1.67% of its portfolio in AbbVie Inc. (NYSE:ABBV). Pinnacle Wealth Advisory Gru Ltd Company invested in 0.58% or 11,287 shares. Asset One Company Limited stated it has 2.61 million shares. Iron Financial Ltd invested 0.22% of its portfolio in AbbVie Inc. (NYSE:ABBV). Toronto Dominion Bancshares holds 0.19% in AbbVie Inc. (NYSE:ABBV) or 652,814 shares.

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 9 Hold. Therefore 48% are positive. Abbvie Inc had 78 analyst reports since July 21, 2015 according to SRatingsIntel. On Monday, October 31 the stock rating was downgraded by Credit Suisse to “Neutral”. The firm has “Buy” rating by Goldman Sachs given on Friday, March 10. SunTrust maintained the stock with “Buy” rating in Sunday, October 29 report. BMO Capital Markets maintained it with “Hold” rating and $6600 target in Sunday, July 30 report. As per Monday, January 29, the company rating was maintained by Credit Suisse. The rating was upgraded by Citigroup on Monday, September 28 to “”. The stock of AbbVie Inc. (NYSE:ABBV) earned “Buy” rating by Jefferies on Thursday, January 4. The stock of AbbVie Inc. (NYSE:ABBV) has “Buy” rating given on Tuesday, December 5 by Leerink Swann. The rating was downgraded by UBS on Monday, September 25 to “Neutral”. Jefferies maintained the stock with “Buy” rating in Monday, May 29 report.

Since August 21, 2017, it had 0 insider purchases, and 11 selling transactions for $4.52 million activity. On Monday, January 22 the insider Gane Stephen C sold $360,021. Another trade for 1,190 shares valued at $47,927 was made by Veltman Kevin J. on Wednesday, January 3. The insider Ramirez Michael F. sold 4,091 shares worth $139,000. LOCK ANDREW J also sold $829,564 worth of Herman Miller, Inc. (NASDAQ:MLHR) on Wednesday, September 27. 5,353 shares valued at $186,552 were sold by Lopez Hezron T. on Wednesday, September 27.

Among 4 analysts covering Herman Miller (NASDAQ:MLHR), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Herman Miller had 6 analyst reports since December 18, 2015 according to SRatingsIntel. The rating was downgraded by BB&T Capital on Friday, June 24 to “Hold”. On Tuesday, December 26 the stock rating was upgraded by Raymond James to “Buy”. Seaport Global initiated the stock with “Neutral” rating in Friday, November 4 report. The stock of Herman Miller, Inc. (NASDAQ:MLHR) earned “Mkt Perform” rating by Raymond James on Friday, December 18. The firm earned “Underperform” rating on Tuesday, January 3 by Raymond James. Sidoti initiated Herman Miller, Inc. (NASDAQ:MLHR) rating on Tuesday, June 27. Sidoti has “Buy” rating and $3800 target.

Investors sentiment increased to 1.36 in 2017 Q3. Its up 0.07, from 1.29 in 2017Q2. It increased, as 15 investors sold MLHR shares while 68 reduced holdings. 37 funds opened positions while 76 raised stakes. 47.85 million shares or 1.06% less from 48.36 million shares in 2017Q2 were reported. Cantab Cap Ltd Liability Partnership holds 0.27% or 52,087 shares. Qs Ltd Co holds 0.03% of its portfolio in Herman Miller, Inc. (NASDAQ:MLHR) for 110,815 shares. Jane Street Gru Llc invested in 7,663 shares or 0% of the stock. Ahl Ltd Liability Partnership stated it has 176,895 shares. 24,858 are owned by Davenport Communication Llc. 454,769 are held by Morgan Stanley. Us Fincl Bank De stated it has 2,974 shares. D E Shaw Inc holds 0% or 5,654 shares. Parallax Volatility Advisers LP accumulated 0% or 172 shares. Quantbot Technologies LP has invested 0.01% in Herman Miller, Inc. (NASDAQ:MLHR). Alabama-based Associated Banc has invested 0.01% in Herman Miller, Inc. (NASDAQ:MLHR). Meeder Asset invested in 0.09% or 23,895 shares. Tower Rech Cap (Trc) holds 0.03% or 9,422 shares in its portfolio. Riverhead Capital Limited stated it has 4,069 shares. Moreover, Citigroup has 0% invested in Herman Miller, Inc. (NASDAQ:MLHR).

Analysts await Herman Miller, Inc. (NASDAQ:MLHR) to report earnings on March, 28. They expect $0.49 EPS, up 25.64% or $0.10 from last year’s $0.39 per share. MLHR’s profit will be $29.24M for 19.21 P/E if the $0.49 EPS becomes a reality. After $0.57 actual EPS reported by Herman Miller, Inc. for the previous quarter, Wall Street now forecasts -14.04% negative EPS growth.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>